| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ff7a3707ef108dd99b8138b8ad2498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32a61a5d4e83262b541743137c525851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8ede091580c0588afb735a1b7650895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8cfe9473c55b0a276a806b3374c42aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95f0636a1180a4f88d7584f973fbd52b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59cc389bbe7dcb4759e9531a969cdfc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4410e3c0501fddac28a16404b720d18c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2005-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e210fe59ffa6e1ae3cfe3471a84940fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f6e163a5f6bc7bfa9a2265ecaba7cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4cce8c078609e4a03fad5da0c3c6f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b019249a5e2fc4f033f771870d9ee50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1dea3767f968afb478c5b0e15aa1775 |
| publicationDate |
2006-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006037611-A2 |
| titleOfInvention |
Methods for the early diagnosis of viral infections, inflammatory diseases, a predisposition for proliferative disorders or hyperplasia by analysing eag or erg expression levels |
| abstract |
The present invention provides a method for the identification of the predisposition of a subject for a proliferative disorder or a hyperplasia and a method for the early diagnosis of a viral infection or an inflammatory disease, comprising the step of analyzing the level of expression of an ether à go-go (EAG) potassium channel gene and/or an ether à go-go related gene (ERG) or the activity of a corresponding gene product in a sample of tissue or cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10082508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013171642-A1 |
| priorityDate |
2004-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |